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Clinical Outcome After Rectal Replacement With Side-to-End,
Colon-J-Pouch, or Straight Colorectal Anastomosis Following
Total Mesorectal Excision
A Swiss Prospective, Randomized, Multicenter Trial (SAKK 40/04)
Walter R. Marti, MD, Gaudenz Curti, MD, Heinz Wehrli, MD,y Felix Grieder, MD,z Michael Graf, MD,§
Beat Gloor, MD, Markus Zuber, MD,jj Nicolas Demartines, MD, Fabrizio Fasolini, MD,yy
Bruno Lerf, MD,zz Christoph Kettelhack, MD,§§ Christiane Andrieu, PhD, SAKK,
Martin Bigler, PhD, SAKK, Stefanie Hayoz, PhD, SAKK, Karin Ribi, PhD, IBCSG, and
Christian Hamel, MDjjjj, the Swiss Group for Clinical Cancer Research (SAKK), Section Surgery
Objective: To compare, in a phase 3, prospective, randomized, multi-center
clinical trial functional outcome of reconstruction procedures following total
mesorectal excision (TME).
Summary Background Data: Intestinal continuity reconstruction following
TME is accompanied by postoperative defecation dysfunctions known as
‘‘anterior resection syndrome.’’ Commonly used reconstruction techniques
are straight colorectal anastomosis (SCA), colon J -pouch (CJP), and side-to-
end anastomosis (SEA). Comparison of their functional outcomes in pro-
spective, randomized, multi-center studies, including long-term assessments,
is lacking.
Methods: Patients requiring TME for histologically proven rectal tumor, with
or without neoadjuvant treatment, age  18 years, normal sphincter function
without history of incontinence, any pretreatment staging or adenoma,
expected R0-resection, were randomized for standardized SCA, CJP, or
SEA procedures. Primary endpoint was comparison of composite evacuation
scores 12 months after TME. Comparison of composite evacuation and
incontinence scores at 6, 18 and 24 months after surgery, morbidity, and
overall survival represented secondary endpoints. Analysis was based on ‘‘per
protocol’’ (PP) population, fully complying with trial requirements, and
intention-to treat (ITT) population.
Results: Three hundred thirty-six patients from 15 hospitals were random-
ized. PP population included 257 patients (JCP¼ 63; SEA¼ 95; SCA¼ 99).
Composite evacuation scores of PP and ITT populations did not show
statistically significant differences among the 3 groups at any time point.
Similarly, composite incontinence scores for PP and ITT populations showed
no statistically significant difference among the 3 trial arms at any time point.
Conclusions: Within boundaries of investigated procedures, surgeons in
charge may continue to perform reconstruction of intestinal continuity
following TME at their technical preference.
Keywords: colon J-pouch, colorectal reconstruction, evacuation score,
incontinence score, Mesorectal excision, side-to-end anastomosis, straight
colorectal anastomosis, straight colorectal anastomosis
(Ann Surg 2018;xx:xxx–xxx)
S urgical resection represents the mainstay of treatment for rectaltumors. Thanks to surgical technical progress, in a majority of
cases the sphincter complex can be spared and a rectal reconstruction
can be performed. However, despite successful reconstruction of
intestinal continuity, normal functions are not fully restored, and
postoperative symptoms, including fecal incontinence, urgency, and
high frequency of defecation, have been described as ‘‘anterior
resection syndrome.’’1,2
To improve functional outcome of straight colorectal anasto-
mosis (SCA), a variety of procedures have been proposed. In
particular, Lazorthes and Parc introduced the colon J-pouch (CJP)
approach.3,4 However, due to defecatory dysfunctions, this form of
reconstruction has largely been updated by substantially shortening J
pouches. Side-to-end anastomosis (SEA)5 has also been used to form
even smaller reservoirs, thereby combining advantages of the 5 cm
CJP, namely safer anastomosis and lower stool frequencies, with
those of SCA, including better evacuation and lesser fragmentation.
Although additional techniques, such as ileocoecal interposition6 and
transverse coloplasty7 have also been developed, technical complex-
ity, safety reasons, and debated functional outcome have prevented
their widespread adoption.
Randomized, controlled trials comparatively investigating
functional outcomes of different techniques have indeed been con-
ducted.8 However, studies comparing most frequently used proce-
dures, SEA, CJP and SCA, are generally characterized by limited
statistical power due to relatively small numbers of patients included.
Furthermore, they frequently represent single-center experiences or
report short-term results only.9–16
To fill this knowledge gap, in a multi-institutional, random-
ized, controlled trial, we have compared long-term functional
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This work was partially supported by a grant from Oncosuisse (OCS 01579-08-
2004) and by the Swiss State Secretariat for Education, Research and Innova-
tion (SERI).
The authors report no conflicts of interest.
Supplemental digital content is available for this article. Direct URL citations
appear in the printed text and are provided in the HTML and PDF versions of
this article on the journal’s Web site (www.annalsofsurgery.com).
Reprints: Walter R. Marti, MD, Prof Dr. med., chirurgieaarau, Bahnhofstrasse 24,
5000 Aarau, Switzerland. E-mail: Walter.R.Marti@hin.ch.
Copyright  2018 Wolters Kluwer Health, Inc. All rights reserved.
ISSN: 0003-4932/16/XXXX-0001
DOI: 10.1097/SLA.0000000000003057
Annals of Surgery  Volume XX, Number XX, Month 2018 www.annalsofsurgery.com | 1
RANDOMIZED CONTROLLED TRIAL
Copyright © 2018 Wolters Kluwer Health, Inc. Unauthorized reproduction of this article is prohibited.s
o
u
r
c
e
:
 
h
t
t
p
s
:
/
/
d
o
i
.
o
r
g
/
1
0
.
7
8
9
2
/
b
o
r
i
s
.
1
2
5
7
7
4
 
|
 
d
o
w
n
l
o
a
d
e
d
:
 
2
7
.
1
2
.
2
0
2
0
CE: D.C.; ANNSURG-D-17-02316; Total nos of Pages: 9;
ANNSURG-D-17-02316
outcomes of 5 cm CJP and SEA with SCA reconstruction
following TME.
METHODS
Trial Design and Participants
This phase 3, prospective, randomized trial was performed in
collaboration by a group of 15 Swiss hospitals, including 4 Univer-
sity hospitals, 3 central hospitals, and 8 regional hospitals. On the
basis of the different reconstruction techniques under investigation,
the trial design consisted of 3 arms: 5 cm CJP, SEA, and SCA.
Eligibility criteria included: histologically proven rectal ade-
nocarcinoma or rectal adenoma with or without neoadjuvant radio-
therapy or radio-chemotherapy; TME requirement; age  18 years;
clinically normal function of sphincter muscles with no history of
frequent fecal incontinence for liquid or solid stools; pretreatment
staging of any T, N, M or adenoma; expected R0-resection whereas
resectable synchronous metastases did not lead to exclusion; com-
pleted baseline interview on evacuation and incontinence.
Exclusion criteria were: rectal cancer surgery other than local
excision in the previous 2 months; planned adjuvant postoperative
radiotherapy; histologically proven chronic inflammatory bowel
disease; contraindication for any of the surgical reconstruction
techniques under investigation; a BMI >35 kg/m2; psychiatric,
addictive or any disorder prohibiting giving informed consent;
inability to read and understand any of the languages available on
questionnaires and spoken during the interviews (German, French,
Italian).
The full Protocol is available in supplementary materials.
Procedures
Following standardized tumor staging, patients were either
operated as soon as possible or, preferably, 1 week after short course
radiotherapy, or 4 to 10 weeks after completion of neoadjuvant
treatment, according to international guidelines.17
TME had to be performed according to Heald et al18 in an
open surgical approach or laparoscopically, according to discretion
and experience of individual surgeon in charge of the intervention.
The 3 types of reconstruction had to be performed in a
standardized way by surgeons experienced in all 3 reconstruction
techniques. To minimize technical variations, a detailed description
of the 3 types of reconstruction was provided. As an example, in the
case of CJP, length of longitudinal stabling should not exceed 5 cm.
For SEA, the blind end of the neorectum should be 4 cm long.
Anastomosis had to be performed either using a circular stapling
devise by double stapler technique, or transanally, by pull through
technique by hand, using an interrupted suture. At discretion of the
surgeon in charge, a temporary ileostomy could be constructed for
reconstruction protection. If the randomized form of reconstruction
was not feasible for safety reasons, the surgeon in charge was allowed
to choose one of the 2 remaining reconstruction techniques.
OUTCOMES
Primary objective was to compare 5 cm CJP, SEA, and SCA
reconstruction techniques following TME, regarding defecation
quality and evacuation problems. Therefore, the composite evacua-
tion score 12 months after TME was defined as primary endpoint of
the study.
Secondary objectives were the comparison of the 3 recon-
struction techniques regarding composite evacuation scores at 6, 18,
and 24 months after surgery; composite incontinence scores, as
assessed at the same time points; morbidity; overall survival and
rate of noncompliance with randomization.
Baseline functional assessments were derived from a struc-
tured interview led by clinicians in charge. Following surgery,
functional outcomes were assessed at 6, 12, 18, and 24 months by
trained study nurses, members of the SAKK Coordinating Center, by
structured phone interviews. To allow unbiased, standardized evalu-
ation of anorectal function, they were independent of surgeons or
surgical institutions involved in the trial. Questionnaires were sent to
patients 1 week before telephone interviews to facilitate conversation
and familiarize patients with questions. Considering that anterior
resection syndrome symptoms could be characterized by day-to-day
variations, patients were asked to provide answers best describing
their daily life.19 Overall, 9 questionnaires (<1%) could not be filled
by patients, since they were unable to give the required information.
In these cases, follow-up forms were sent to the general practitioner
for completion.
Composite Evacuation Score
Functional outcome regarding evacuation ability was evalu-
ated according to published assessment and scoring instruments.20
They analyze different functional aspects, such as use of medication
to evacuate, difficulties to empty, digitation to evacuate, return to
evacuate, feeling of incomplete evacuation, straining to evacuate, and
time needed to evacuate. Patients were asked to subjectively evaluate
each of these aspects per given response categories, resulting in 7
subscores, each between 0 and 3.
If all 7 questions were answered, the composite evacuation
score was the sum of the seven subscores, yielding a total between 0
and 21, with lower scores associated to better function. If 6 of 7
questions were answered, composite evacuation score was calculated
as 7/6 times the sum of the 6 available subscores. Scores for patients
with 5 or less answered questions were not calculated.
Composite Incontinence Score
Functional outcome regarding continence was assessed by a
similar composite incontinence score, evaluating different aspects of
incontinence, including warning before passing motion, ability to
differentiate gas from feces, ability to defer evacuation, wearing a
pad during the day, wearing a pad at night, incontinence of
gas, incontinence of loose stool, incontinence of feces.8 Summary
score ranges from 0 to 24 with lower scores associated with
better function.
Randomization and Masking
Patients were allocated by using the minimization method and
were stratified based on enrolling surgical clinic, patient’s gender,
distance of the distal tumor margin from the dentate line (>5 cm vs.
5 cm), age (<70 vs. 70 years), neoadjuvant treatment (no/yes),
and distant metastatic disease (M0 vs. M1).
Staff SAKK members in charge of telephone interviews of
enrolled patients 6 to 24 months after surgery, were independent of
surgeons, blinded to the selected reconstruction method, and were
located at the SAKK Coordinating Center in Bern, with no attach-
ments to hospitals involved in the study.
Oncologic Outcome, Morbidity, and Mortality
Participating surgical centers had to fill specific assessment
forms. Short-term, 30-day, morbidity evaluation focused on septic
problems, anastomotic leakage and reoperation. Regarding long-
term morbidity, formation of anastomotic stenosis or perianal fistula,
and non-closure of protective stoma were assessed until the end of
the study period (24 months). Overall and disease specific survival
and mortality were evaluated up to 24 months after surgery or
until death.
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Statistical Analysis
Main statistical analysis was based on ‘‘per protocol’’ (PP)
population, a subset of patients of the intention-to treat (ITT)
population fully complying with protocol requirements. Patients
treated with reconstruction procedures other than the randomized
one or patients undergoing adjuvant pelvic radiotherapy were
excluded from the PP population. Therefore, all patients in the PP
population were analyzed according to the surgery they
actually received.
The sample size of 82 evaluable patients in each treatment arm
was calculated according to Horn and Vollandt,21 with a type I error
rate of 5% and a power of 90% for each pair of comparisons. Sample
size was then inflated by 15% resulting in a total of 282 patients. A
second safety analysis showed a substantially higher than expected
rate of nonevaluable patients (33%). Therefore, patients’ number was
further increased (n ¼ 54) to a total of 336.
For primary analysis, composite evacuation scores associated
with the 3 reconstruction techniques at 12 months were compared
using pairwise, 2-sided, Steel multiple comparison Wilcoxon tests.22
For other analyses, overall comparisons across arms were
carried out using chi-squared, Kruskal–Wallis, and log-rank tests for
categorical, continuous, and time-to-event variables, respectively. If
there were significant overall differences, pairwise comparisons were
carried out using chi-squared, Mann–Whitney, and log-rank tests for
categorical, continuous, and time-to-event variables.23
To take into account covariates other than treatment arm, linear
mixed effect models, with surgeon as random effect, were used for
continuous variables. Continuous data were summarized using median
and range, and categorical data using frequency and percentage.
Two-tailed tests with significance level of 0.05 were used for
all analyses. As no adjustment for multiple testing other than primary
endpoint evaluation was applied, analyses were exploratory and
hypothesis generating. All analyses were performed using SAS
9.4 (SAS Institute) and R 3.2.4 (http://www.r-project.org).
Ethics and Safety Surveillance
It was anticipated that for a certain number of patients,
randomized reconstruction would not be feasible due to technical
reasons such as length of remaining colon not allowing to safely
perform CJP. As patient’s safety was the most important factor, any
uncertain condition during surgery allowed the surgeon to overrule
randomization. In these cases, the surgeon could choose one of the
other techniques.
Laparoscopic resection was allowed if the operating surgeon
had an experience of> 30 laparoscopic colorectal resections prior to
participation to the trial. Surgery, neoadjuvant, and adjuvant treat-
ments were applied individually, as recommended by local tumor
boards, and according to accepted international guidelines.17
The SAKK Coordinating Center in Bern supervised the study
at all 15 participating surgical sites and provided continuous on-site
monitoring. Surgical and other complications were analyzed as
anonymized reports being evaluated and submitted yearly to an
international ‘‘surgical safety panel’’ composed of surgeons not
involved in any way in the trial.
A first interim safety analysis was performed after inclusion of
50 patients in the trial. Decision to stop the study would have been
based upon safety concerns, surgical noncompliance and low accrual.
Criteria for this decision were specified in the protocol and strictly
followed after the results of the interim safety analysis became
available. The trial was allowed to continue upon consideration of
all 5 conducted interim safety analyses.
The trial, registered with ClinicalTrials.gov, number
NCT00238381), was planned and conducted in accordance with
the Declaration of Helsinki, Guidelines for Good Clinical Practice,
issued by the International Conference on Harmonization and
requirements of respective national regulatory authorities. Respec-
tive ethics committees of all participating centers approved the trial
and written informed consent was obtained from all patients prior
to enrolment.
Role of Funding Sources
The study was supported by Oncosuisse (OCS 01579-08-
2004) and the Swiss State Secretariat for Education, Research and
Innovation (SERI). Funders had no influence on study design, data
collection, analysis and interpretation, or report writing.
RESULTS
Patient Population and Data Acquisition
In the 15 participating hospitals 336 patients were enrolled
between November 2005 and May 2014 (Fig. 1). The 4 university
centers, 4 referral centers, and 7 peripheral clinics contributed 104
(5–40), 152 (27–44), and 80 (1–33) patients, respectively. One
hundred twelve patients were randomized to each treatment arm.
Randomized groups did not show any significant difference regard-
ing preoperative characteristics (Table 1). One patient randomized to
CJP reconstruction withdrew his consent after surgery had been
performed. Moreover, 68 patients (arm CJP ¼ 47, arm SEA ¼ 12,
arm SCA ¼ 9) were not treated according with the reconstruction
procedure they were randomized to. In particular, in 8 patients, rectal
cancer could only be removed by abdomino-perineal rectal ampu-
tation, and in 5 patients a Hartmann operation was performed. In 1
patient, a colo-anal sleeve anastomosis was constructed below the
dentate line. In 3 cases patients randomized for the SCA group
underwent SEA because colon was too short and in accord with
surgeon’s decision. For 10 patients, a preoperatively unplanned
adjuvant radiotherapy treatment had to be performed. To exclude
any influence of radiation therapy on functional results, these
patients were excluded from analysis, according to the protocol.
Thus, PP population included 257 patients (CJP¼ 63, 56.3%; SEA¼
95, 84.8%; SCA ¼ 99, 88.4%).
At registration, median age of patients was 68.6 years (30.9–
85.5) in arm CJP, 67.2 years (32.3–88.9) in arm SEA, and 66.3 years
(32.3–90.9) in arm SCA. Median BMI was, 24.2 kg/m2 in arm CJP,
24.3 kg/m2 in arm SEA and 25.2 kg/m2 in arm SCA. Patient and
tumor characteristics are summarized in Table 1. Due to a variety of
reasons (patient lost for follow-up, too ill, refusing to cooperate,
missing answers or unknown background), composite evacuations,
and composite incontinence scores were not recorded after 6, 12, 18,
and 24 months for 23, 27, 34, and 34 patients and 23, 24, 32, and 32
patients, respectively.
Clinical and Oncological Outcome
In 164 of 322 patients (50,9%), surgery was performed
laparoscopically. Overall morbidity rate was 50.3% (162/322) and
included pulmonary, cardiac, renal, gastrointestinal, and thrombo-
embolic complications, as well as bleeding and infections. Surgical
site infection rate was 27.3% including superficial infection only in
7.5% (24/322), deep incisional infection in 2.8% (9/322), and
abdominal infection in 12.4% (40/322) of patients. Anastomotic
leak rate was 12.1% (39/322). During initial hospital stay, 14.3%
(46/322) of patients needed surgical reintervention. Stomas from 236
patients of the ITT population (76%) and 193 of the PP patient
population (82%) were closed within 9 months following TME.
Thirty days mortality among all patients was 1.79% (6/335).
Tumor resection was confirmed to be complete (R0) in 96.6%
(311/322), microscopically incomplete (R1) in 1.9% (6/322), and
staged as Rx or unknown in 1.6% (5/322) of patients. In specimens
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from the 311 completely resected patients, median circumferential
resection margin was 12 mm (0.5–70 mm), and median distal resec-
tion margin was 25 mm (2–99 mm). Overall, 34 of 335 (10.1%)
patients experienced a relapse (local, distant, or both) within 1 year
following surgery, and 59 of 335 (17,6%) within 24 months. Overall
survival in the cohort was 94.6% (95% confidence interval (CI)
91.6–96.6%), and 90.6% (95% CI 87.0–93.3%) at 12 and 24
months, respectively.
No statistically significant differences in morbidity, mortality,
local or distant metastases, and overall survival were observed
among patients included in the different treatment arms (supplemen-
tary extended results, Tables 93–104, http://links.lww.com/SLA/
B515).
Evacuation Capacity
Functional assessments were performed at defined times after
TME.8 Among the 257 patients in PP populations, composite evac-
uation scores at 6, 12, 18, and 24 months following surgery were
available for 160 (62.3%), 194 (75.5%), 188 (73.2%), and 179
(69.6%) patients. Remaining patients could not be analyzed due
to permanent stoma (Hartmann procedure or abdomino-perineal
resection), stoma still in place, death, too ill, refusal to cooperate,
lost for follow-up or missing data. Composite evacuation scores for
PP populations did not show any statistically significant difference
among the 3 groups under investigation at any time point considered
(Fig. 2).
To strengthen the significance of our data, primary analysis
was repeated for the whole ITT population (n ¼ 335). Composite
evacuation scores at 6, 12, 18, and 24 months after surgery were
available for 185 (55%), 232 (69%), 229 (68%), and 213 (64%)
patients, respectively. Again, no significant differences were detect-
able at any time point (Fig. 2).
Importantly, neoadjuvant treatment did not appear to be
associated with unfavorable, higher composite evacuation
scores following surgery, at any time point under investigation,
irrespective of surgical procedures, and in both PP and ITT
populations (supplementary Table 1A-B, http://links.lww.com/
SLA/B515).
Capacity of Continence (Secondary Outcome)
Among the 257 patients in PP population, composite inconti-
nence scores at 6, 12, 18, and 24 months after surgery were available
for 160 (62.3%), 197 (76.7%), 188 (76.7%), and181 (70.4%)
patients, respectively. Remaining patients could not be analyzed
due to permanent stoma (Hartmann procedure or abdomino-perineal
resection), stoma still in place, death, too ill and refusal to answer
specific questions, lost for follow-up or missing data. Composite
incontinence scores for the PP population showed no statistically
significant difference among the 3 arms under investigation at any
time point, as depicted in Figure 3. Similar observations were made
for the ITT population, as well.
Quality of life data will be reported in a dedicated paper (Ribi
et al., 2018, in preparation). Nevertheless, remarkably, patients with
more severe evacuation problems did not report a significantly worse
quality of life, as compared to patients with less severe
evacuation problems.
Consistent with evacuation scores (see above), neoadjuvant
treatment prior to surgery did not affect composite incontinence
scores in PP and ITT populations (supplementary Table 2A-B, http://
links.lww.com/SLA/B515). On the other hand, levels of anastomosis
appeared to impact composite incontinence scores at 12, 18, and
24 months in both PP and ITT populations (supplementary Table 3A-
B, http://links.lww.com/SLA/B515). However, due to high data
dispersion, significance threshold was not reached.
DISCUSSION
Bowel dysfunction represents a major problem following
TME. A variety of surgical procedures have been developed to
prevent anterior resection syndrome.24,25 SCA, CJP, and SEA are
the most widely used techniques. Other procedures are less fre-
quently utilized. In particular, transverse coloplasty pouch7 has been
associated with a higher leak rate, as compared with JP,10 and
ileocecal interposition as neorectum is less established,27 mainly
because of potential risks and absence of functional advantages.11
A comprehensive, comparative analysis of functional out-
comes associated with SCA, CJP, and SEA is still lacking.
FIGURE 1. Trial profile.
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In a prospective, randomized, 2-arm trial, Hallböök et al12
observed an advantageous incontinence score for CJP reconstructed
patients over no pouch formation after 2 months, less evident
12 months after surgery. However, in this study only 93 patients
were analyzed for functional outcome. Furthermore, pouch was up to
8 cm long and 10% of pouch patients needed enemas on regular basis
for stool evacuation.
Other studies have compared CJP and SCA in smaller groups
of patients (n48).13,14 Furthermore, functional outcomes were only
evaluated at 3 to 12 months. CJP advantage was only observed in
early months after surgery, or was undetectable.13,14 A meta-analysis,
pooling results from comparative studies revealed a functional
advantage for pouch reconstruction up to 1 year following surgery.26
A more recent meta-analysis indicates that, CJP, SEA, or transverse
TABLE 1. Preoperative Patient Characteristics (PP Population)
Variable Arm CJP (n ¼ 63) Arm SEA (n ¼ 95) Arm SCA (n ¼ 99)
ASA status
Healthy 9 (14.3%) 17 (17.9%) 8 (8.1%)
Mild systemic disease 42 (66.7%) 53 (55.8%) 65 (65.7%)
Severe systemic disease 12 (19.0%) 24 (25.3%) 24 (24.2%)
Severe systemic disease that is a constant threat to life 1 (1.1%) 2 (2.0%)
Type of lesion
Adenocarcinoma 59 (93.7%) 94 (98.9%) 97 (98.0%)
Adenoma 2 (3.2%) 1 (1.1%) 2 (2.0%)
Other 2 (3.2%)
Patient has concomitant disease
No 25 (39.7%) 42 (44.2%) 33 (33.3%)
Yes 38 (60.3%) 53 (55.8%) 66 (66.7%)
Abdominal surgery performed previously
No 33 (52.4%) 58 (61.1%) 68 (68.7%)
Yes 30 (47.6%) 37 (38.9%) 31 (31.3%)
Neoadjuvant therapies administered
No 14 (22.2%) 25 (26.3%) 20 (20.2%)
Yes 49 (77.8%) 70 (73.7%) 79 (79.8%)
Type of neoadjuvant therapies administered (more than one possible)
Chemotherapy 3 (3.2%) 4 (4.0%)
Combined chemoradiotherapy 45 (71.4%) 66 (69.5%) 70 (70.7%)
Radiotherapy 4 (6.3%) 3 (3.2%) 6 (6.1%)
Method of assessment (more than one possible)
Abdominal/pelvic CT 14 (22.2%) 30 (31.6%) 25 (25.3%)
Abdominal/pelvic MRI 17 (27.0%) 24 (25.3%) 23 (23.2%)
Abdominal ultrasound 2 (3.2%) 8 (8.4%) 6 (6.1%)
Endorectal ultrasound 31 (49.2%) 39 (41.1%) 47 (47.5%)
PET 2 (3.2%) 3 (3.2%) 1 (1.0%)
Rectal MRI 5 (7.9%) 9 (9.5%) 9 (9.1%)
Other 1 (1.1%)
Distance of distal tumor margin from dentate line (cm) 6.0 (1.0–11.0) 7.0 (1.0–15.0) 5.0 (1.0–12.0)
T classification preoperative
T0 1 (1.0%)
T1 3 (4.8%) 4 (4.2%) 4 (4.0%)
T2 11 (17.5%) 17 (17.9%) 14 (14.1%)
T3 48 (76.2%) 69 (72.6%) 73 (73.7%)
T4 1 (1.6%) 4 (4.2%) 5 (5.1%)
Tx 1 (1.1%) 2 (2.0%)
N classification preoperative
N0 17 (27.0%) 29 (30.5%) 27 (27.3%)
N1 32 (50.8%) 40 (42.1%) 48 (48.5%)
N2 6 (9.5%) 18 (18.9%) 19 (19.2%)
Nx 8 (12.7%) 8 (8.4%) 5 (5.1%)
M classification preoperative
M0 61 (96.8%) 91 (95.8%) 92 (92.9%)
M1 2 (3.2%) 4 (4.2%) 7 (7.1%)
UICC classification preoperative
0 1 (1.0%)
I 11 (17.5%) 15 (15.8%) 11 (11.1%)
II 13 (20.6%) 18 (18.9%) 16 (16.2%)
III 37 (58.7%) 57 (60.0%) 62 (62.6%)
IV 2 (3.2%) 4 (4.2%) 7 (7.1%)
Missing 1 (1.1%) 2 (2.0%)
Type of distant metastases (more than one possible)
Liver 1 (1.6%) 3 (3.2%) 4 (4.0%)
Lung 2 (3.2%) 1 (1.1%) 4 (4.0%)
Other 1 (1.0%)
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FIGURE 2. Composite evacuation scores. Randomized patients were treated according to the indicated surgical procedures.
Evacuation scores were evaluated at the indicated time points. Data are expressed as median changes from baseline, with 95%
confidence limits. Data refer to protocol (PP, upper panel) and intention-to-treat (ITT, lower panel) populations, respectively.
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FIGURE 3. Composite incontinence scores. Composite incontinence scores were obtained from randomized patients treated
according to the indicated surgical procedures at the indicated time points. Data, expressed as median changes from baseline with
95% confidence limits, refer to protocol (PP, upper panel) and intention-to-treat (ITT, lower panel) populations, respectively.
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coloplasty reconstruction do show advantages over SCA only within
the first year following surgery.27 However, nonrandomized studies
have also been included in this report.
Markovic et al could not observe improved defecatory func-
tion upon CJP, as compared with SEA reconstruction, in a study
including 80 patients, at 6, 12, and 24 months.28 These results are
largely in accordance with a meta-analysis by Si et al15 and data from
a randomized study by Machado et al.16
To our knowledge, our clinical trial is the largest prospective,
randomized study in the field of rectal cancer surgery, investigating
functional outcomes of 2 different pouch reconstruction techniques
in comparison with SCA baseline treatment. Altogether, it has
involved 15 hospitals, including universities, referral centers, and
regional hospitals, each contributing from 1 to 44 rectal resections.
Remarkably, despite this variety, results are comparable, in terms of
technical and oncological quality, to other published series.11,29–31
For instance, anastomotic leakage rate represents a reliable technical
surrogate marker for quality control, and Boyce et al32 have reported
a leakage rate of 12.9% following laparoscopic rectal resection with
anastomoses below 6 cm. Indeed, a comparable leakage rate (12.1%)
was also observed in our study.
Our data clearly document that, regarding evacuation, forma-
tion of neo-rectal pouch does not provide functional advantages, as
compared with SCA and SEA, over a 6 to 24 months postoperative
observation. Furthermore, the type of reconstruction does not appear
to influence continence capacity.
This study also provides additional results of potential clinical
relevance. In particular, although neoadjuvant therapy has been
suggested to increase the risk of bowel dysfunction following
surgery,33–37 it did not appear to be associated with unfavorable
evacuation or incontinence scores in our patients. However, our
findings should be considered cautiously, since numbers of untreated
patients, analyzed as controls (Table 1 and extended results, pages
20–21), were relatively low (n¼ 24, 28, and 25, respectively, for the
3 arms under investigation in the ITT population, and n¼ 14, 25, and
20, respectively, for the 3 arms under investigation in the PP
population).
While the trial was not designed to investigate incontinence as
related to level of anastomoses, nevertheless, our data may suggest a
worse long-term continence capacity for patients bearing anastomo-
ses performed close to or at the dentate line. These findings are in line
with published reports investigating the functional impact of anasto-
motic levels following CJP anastomoses.38
Limitations of our study should be acknowledged. In particu-
lar, an important limitation might be represented by the use of
relatively rarely utilized composite evacuation and incontinence
scores.20 However, currently validated scores, such as the LARS
score,19 were not available at the time of the initiation of this clinical
trial. Furthermore, although they are simple and easily applied in an
international context,39 they largely fail to account for evacuation-
related symptoms frequently observed following TME, including use
of medications to evacuate, stool fragmentation, leading to difficul-
ties to empty, digitation to evacuate, feeling of incomplete evacua-
tion, straining to evacuate, and increased time needed to evacuate. In
contrast, evaluation of these symptoms is specifically included in the
evacuation score utilized in our study, initially developed by Heald’s
group.20 Furthermore, additional frequently observed symptoms,8
including warning before passing motion, ability to differentiate gas
from feces, and wearing a pad during the day or at night, are
considered in the composite incontinence score, but are not
addressed in simpler instruments. Therefore, the questionnaire uti-
lized in our study20 provides a highly detailed picture of symptoms
experienced by patients following TME.
On the other hand, surgeon’s human contact to the patients
formed the basis to motivate them for participation in a study, where
one of the most important surgical steps, reconstruction, was chosen
at random. Therefore, only a fraction of all patients treated within
participating centers could be included in this study, thereby explain-
ing their low numbers per year and center. Furthermore, unsurpris-
ingly, particularly in patients randomized to the CJP arm, due to
safety reasons, surgeons in charge occasionally reconstructed bowel
continuity not according to randomized, but rather to technically
simpler procedures. This may weaken, to some extent, the level of
evidence of our results. However, regarding postoperative assess-
ments and interviews, study design precluded any influence of
patient’s gratitude for the individual surgeon. Indeed, study nurses
acquired data in a centralized, nonclinical and non-hospital, office
setting. Furthermore, due to limited number of study nurse staff,
observer-related variability was minimal, with low potential biases.
In conclusion, our data indicate that, within the boundaries of
the 3 procedures investigated in this study, surgeons in charge may
continue to perform reconstruction of intestinal continuity following
TME at their technical preference.
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